Evidence map›Paper›PMID 33434393›Full record

ArticleAdvanced healthcare materials2021

Encapsulated Mesenchymal Stromal Cell Microbeads Promote Endogenous Regeneration of Osteoarthritic Cartilage Ex Vivo.

Neety Sahu, Pranay Agarwal, Fiorella Grandi, Michela Bruschi, Stuart Goodman, Derek Amanatullah, Nidhi Bhutani

Open access · greenAbstract read
In one paragraph

Article in Advanced healthcare materials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A dynamically loadedFrontiers in cell and developmental biology · 2024
    Article
  5. Article
  6. Visualizable and Lubricating Hydrogel Microspheres Via NanoPOSS for Cartilage Regeneration.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Functionalized 3D scaffolds for engineering the hematopoietic niche.Frontiers in bioengineering and biotechnology · 2022
    Review
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Neety SahuDepartment of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, CA, 94305, USA.ORCID 0000-0001-5355-0514
Pranay AgarwalDepartment of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Fiorella GrandiNeurological Disease Institute, Gladstone Institutes, University of California, San Francisco, CA, 94107, USA.ORCID 0000-0002-1303-6710
Michela BruschiDepartment of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Stuart GoodmanDepartment of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Derek AmanatullahDepartment of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Nidhi BhutaniDepartment of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, CA, 94305, USA.ORCID 0000-0002-7494-5870
Stanford University · USGladstone Institutes · US

Funding

Evaluating the Potential of Human Induced Pluripotent Stem Cells (hiPSC) For Cartilage RepairR01AR070864 · NIAMS · STANFORD UNIVERSITY · PI BHUTANI, NIDHI · 2017 to 2021
$2.2M
Targeting DNA Demethylation Regulators in OsteoarthritisR01AR070865 · NIAMS · STANFORD UNIVERSITY · PI BHUTANI, NIDHI · 2016 to 2020
$1.7M
NIAMS NIH HHS R01 AR070864NIAMS NIH HHS R01 AR070865
6 · The paper itself

Abstract

The anti-inflammatory secretome of mesenchymal stromal cells (MSCs) is lucrative for the treatment of osteoarthritis (OA), a disease characterized by low-grade inflammation. However, the precise effects of the MSC secretome on patient-derived OA tissue is lacking. To investigate these effects, alginate encapsulated MSCs are co-cultured with patient-derived OA cartilage explants for 8 days. Proteoglycan distribution in OA cartilage explants examined by Safranin O staining is markedly improved when cultured with MSC microbeads as compared to control OA explants cultured alone. Total sulfated glycosaminoglycan (sGAG) content in OA explants is significantly increased upon co-culture with MSC microbeads on day 8. The sGAG released into the culture media is unchanged by the presence of MSC microbeads, suggesting de novo sGAG synthesis in OA explants. Co-culture with MSC microbeads increased the DNA content and Ki67

Indexed as

Cartilage, ArticularMesenchymal Stem CellsOsteoarthritisCartilageCells, CulturedChondrocytesHumansMicrospheresRegenerationmesenchymal stromal cellsosteoarthritisparacrineregenerationsecretome

Identifiers

PMID33434393
PMCPMC10591520
OpenAlexW3119524000

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.